Skip to content
Loading...
Search for:
Search
About
Management
Board of Directors
Advisory Board
History
Governance
General Meetings
Governance reports
Board Committees
Nomination Committee
Articles of Association
Auditor
Code of Conduct
Career
Our Science
Focus Areas
Autoimmune and Inflammatory Diseases
Host-Directed Therapy – Viral Infections
Our Medicines
Oral Drugs
Peptides
Synact Wiki
Diseases
Rheumatoid Arthritis
Nephrotic Syndrome
Polymyalgia Rheumatica
Dengue Fever
COVID-19
Development Program
Resomelagon
Inflammatory and Autoimmune Diseases
RA: The BEGIN Study
RA: The EXPAND Study
RA: The RESOLVE Study
RA: The ADVANCE Study
iMN: SynAct-CS003
Host-Directed Therapy in Viral Infections
COVID-19: RESOVIR-1
Dengue Fever: RESOVIR-2
TXP-11
Investors
Message from the CEO
Investment Highlights
Financial Reports
The Share
Share capital
Ownership Structure
Board and Management Holdings
Analysts
Presentations
Calendar
Prospectus and Rights Issues
News & Media
News and Press Releases
SynAct in the Media
Slide Decks and Presentations
Image Bank
ENG
SVE
Search
Search for:
Search
General Meetings
November 27, 2025
Extraordinary General Meeting November 2025
27 May, 2025
Annual General Meeting 2025
December 13, 2024
Extraordinary General Meeting December 2024
May 31, 2024
Annual General Meeting 2024
April 24, 2024
Extraordinary General Meeting April 2024
March 20, 2024
Extraordinary General Meeting March 2024
May 25, 2023
Annual General Meeting 2023
January 12, 2023
Extraordinary General Meeting January 2023
May 20, 2022
Annual General Meeting 2022
March 28, 2022
Extraordinary General Meeting March 2022
May 21, 2021
Annual General Meeting 2021
November 6, 2020
Extraordinary General Meeting November 2020
November 6, 2020
Extraordinary General Meeting 2020
8 november, 2019
Extra bolagsstämma 2019
May 21, 2021
Årsstämma 2019
21 mars, 2019
Extra bolagsstämma 2019
15 maj, 2018
Årsstämma 2018
10 april, 2018
Extra bolagsstämma 2018